Subject has entered the Maintenance Phase of the double-blind trial SP902 ie has taken at least 1 dose of SP902 Maintenance Phase trial medication and either completed SP902 or met an exit criterion in SP902 subject is allowed up to 2 concomitant Antiepileptic Drugs AEDs 